MIKART FDA Approval ANDA 040658

ANDA 040658

MIKART

FDA Drug Application

Application #040658

Documents

Letter2015-10-22
Label2015-10-27

Application Sponsors

ANDA 040658MIKART

Marketing Status

Prescription001
Prescription002
Prescription003

Application Products

001TABLET;ORAL300MG;5MG0HYDROCODONE BITARTRATE AND ACETAMINOPHENACETAMINOPHEN; HYDROCODONE BITARTRATE
002TABLET;ORAL300MG;7.5MG0HYDROCODONE BITARTRATE AND ACETAMINOPHENACETAMINOPHEN; HYDROCODONE BITARTRATE
003TABLET;ORAL300MG;10MG0HYDROCODONE BITARTRATE AND ACETAMINOPHENACETAMINOPHEN; HYDROCODONE BITARTRATE

FDA Submissions

ORIG1AP2006-01-19
LABELING; LabelingSUPPL4AP2011-06-27
LABELING; LabelingSUPPL6AP2013-10-18STANDARD
LABELING; LabelingSUPPL7AP2016-12-15STANDARD
LABELING; LabelingSUPPL9AP2016-12-16STANDARD
LABELING; LabelingSUPPL10AP2016-12-16STANDARD
LABELING; LabelingSUPPL11AP2018-08-24STANDARD
REMS; REMSSUPPL12AP2018-09-18
LABELING; LabelingSUPPL13AP2018-09-21STANDARD
LABELING; LabelingSUPPL15AP2019-10-11STANDARD
LABELING; LabelingSUPPL16AP2021-03-04STANDARD

Submissions Property Types

SUPPL4Null7
SUPPL6Null15
SUPPL7Null7
SUPPL9Null15
SUPPL10Null7
SUPPL11Null7
SUPPL12Null7
SUPPL13Null15
SUPPL15Null15
SUPPL16Null15

TE Codes

001PrescriptionAA
002PrescriptionAA
003PrescriptionAA

CDER Filings

MIKART
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 40658
            [companyName] => MIKART
            [docInserts] => ["",""]
            [products] => [{"drugName":"HYDROCODONE BITARTRATE AND ACETAMINOPHEN","activeIngredients":"ACETAMINOPHEN; HYDROCODONE BITARTRATE","strength":"300MG;5MG","dosageForm":"TABLET;ORAL","marketingStatus":"Prescription","te":"","rld":"No","rs":"Yes"},{"drugName":"HYDROCODONE BITARTRATE AND ACETAMINOPHEN","activeIngredients":"ACETAMINOPHEN; HYDROCODONE BITARTRATE","strength":"300MG;7.5MG","dosageForm":"TABLET;ORAL","marketingStatus":"Prescription","te":"","rld":"No","rs":"Yes"},{"drugName":"HYDROCODONE BITARTRATE AND ACETAMINOPHEN","activeIngredients":"ACETAMINOPHEN; HYDROCODONE BITARTRATE","strength":"300MG;10MG","dosageForm":"TABLET;ORAL","marketingStatus":"Prescription","te":"","rld":"No","rs":"Yes"}]
            [labels] => [{"actionDate":"10\/18\/2013","submission":"SUPPL-6","supplementCategories":"Labeling-Package Insert","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"\"}]","notes":""}]
            [originalApprovals] => [{"actionDate":"HYDROCODONE BITARTRATE AND ACETAMINOPHEN","submission":"ACETAMINOPHEN; HYDROCODONE BITARTRATE","actionType":"300MG;5MG","submissionClassification":"TABLET;ORAL","reviewPriority":"Prescription","inserts":"[]","notes":">No"},{"actionDate":"HYDROCODONE BITARTRATE AND ACETAMINOPHEN","submission":"ACETAMINOPHEN; HYDROCODONE BITARTRATE","actionType":"300MG;7.5MG","submissionClassification":"TABLET;ORAL","reviewPriority":"Prescription","inserts":"[]","notes":">No"},{"actionDate":"HYDROCODONE BITARTRATE AND ACETAMINOPHEN","submission":"ACETAMINOPHEN; HYDROCODONE BITARTRATE","actionType":"300MG;10MG","submissionClassification":"TABLET;ORAL","reviewPriority":"Prescription","inserts":"[]","notes":">No"}]
            [supplements] => 
            [actionDate] => 2013-10-18
        )

)

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.